(NASDAQ: TIL) Instil Bio's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 9.68%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.82%.
Instil Bio's earnings in 2025 is -$78,033,000.On average, 1 Wall Street analyst forecast TIL's earnings for 2025 to be -$67,698,447, with the lowest TIL earnings forecast at -$67,698,447, and the highest TIL earnings forecast at -$67,698,447. On average, 1 Wall Street analyst forecast TIL's earnings for 2026 to be -$66,583,259, with the lowest TIL earnings forecast at -$66,583,259, and the highest TIL earnings forecast at -$66,583,259.
In 2027, TIL is forecast to generate -$52,348,217 in earnings, with the lowest earnings forecast at -$52,348,217 and the highest earnings forecast at -$52,348,217.